Announcement Dare Bioscience, Inc. is an intention-driven, accelerated biotech company completely targeting covering the gap between real-world solutions and promising science to improve women’s health will be on stage in a live webinar for the DARE to PLAY™ DIFFERENCE following its com...
Announcement Galvanize Therapeutics Inc., a leading marketing pro medical technology company featuring pulsed electric field (PEF) therapies for chronic lung disease and oncology, opted for the online platform to post its positive six-month results from its robust AFFINITY clinical trial in the med...
Announcement Repair Biotechnologies Inc. highlighted its current presentation of preclinical data proving the regression and potential of atherosclerotic plaque with REP-0003 treatment under its preclinical data at the American Heart Association’s (AHA) Scientific Sessions 2025 in New Orlean...
Announcement AN2 Therapeutics, Inc., a leading biopharmaceutical company specialising in small molecule therapeutics with its comprehensive boron chemistry platform, has fixed a research collaboration deal with the leading GSK biopharma company to discover new therapies for tuberculosis (TB). TB h...
Announcement Idorsia Ltd. has published the new evaluation, a slight improvement from the landmark Phase 3 PRECISION study, in the Journal of Hypertension with the title ‘Effects of aprocitentan on prognostically relevant ambulatory blood pressure-derived variables in resistant hypertension....
Announcement INBRAIN Neuroelectronics, a leading brain-computer interface therapeutics (BCI-Tx) company establishing graphene-related neural technologies, has entered a smart partnership with the popular Microsoft company to discover the diversified excellent use of agentic artificial intelligence...
Announcement Ionis intends to form a supplemental page to further submit its potential by the end of the year to extend Tryngolza into an extreme hypertriglyceridemia. If accepted, then William Blair will strengthen its hope, claiming the antisense drug to be known as a transformational one for th...
Announcement Innate Pharma SA proudly declared that they have received clearance by the US Food and Drug Administration (FDA) for the confirmatory Phase 3 protocol for lacutamab in cutaneous T-cell lymphomas (CTCL), undoubtedly with the green signal to proceed with the trial. The TELLOMAK 3 ...
Announcement The new generation of companies has been keeping an eye on the niche-sized hair loss market with fingers crossed for the best new scientific focus and formulations to discover treatments not only effective and safe, but also excelling commercially. The progress of the GLP-1 weight los...
Announcement Hinge Health (HNGE), a leading digital health company offering personalised programs to help individuals deal with musculoskeletal (MSK) pain via virtual care, lifestyle support and exercise therapy, has witnessed a rise in share. The company merges an AI-sponsored platform with human...
